Zacks Research Brokers Increase Earnings Estimates for TEVA

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Equities researchers at Zacks Research raised their FY2025 earnings estimates for shares of Teva Pharmaceutical Industries in a note issued to investors on Thursday, April 3rd. Zacks Research analyst R. Department now anticipates that the company will post earnings of $2.48 per share for the year, […]

Leave a Reply

Your email address will not be published.

Previous post Analysts Issue Forecasts for WCN FY2025 Earnings
Next post Zacks Research Issues Optimistic Outlook for CMC Earnings